Clinical Trial Update: Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronic acid for safety and efficacy in breast cancer with metastatic bone lesions; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Bone Metastasis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer With Bone Metastasis | Phase 3 | Status: COMPLETED | Results posted: 2011-08-04